AUPHAurinia Pharmaceuticals Inc.vs its industry peers
A metric-by-metric comparison of Aurinia Pharmaceuticals Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPH본 종목 | $2.1B#3 | 7.1x#1 | 3.5x#2 | 7.6x#1 | 20.4%#4 | 4851.7%#1 | 37.1%#1 | 46.7%#1 | — | — | 28.9%#2 | — |
| ALMS | $1.1B#4 | — | 2.3x#1 | 44.2x#2 | — | 17.3%#6 | -1886.9%#4 | -53.8%#3 | — | — | — | — |
| ANL | — | — | — | — | — | 52.5%#4 | -1058.6%#3 | — | — | — | 738.5%#1 | — |
| APLM | $53M#6 | — | — | — | — | 68.8%#2 | — | — | — | — | — | — |
| APLMW | $24815#10 | — | — | — | — | 68.8%#2 | — | — | — | — | -63.4%#7 | — |
| ASND | $14.9B#2 | — | — | — | — | — | — | — | — | — | 21.7%#3 | — |
| ATAI | — | — | — | — | 1227.6%#1 | -342.2%#9 | -15751.1%#7 | -374.2%#4 | -2107.6%#1 | — | — | — |
| ATHE | $800M#5 | — | — | — | — | — | — | — | — | — | -20.0%#4 | — |
| AXIM | — | — | — | — | 434.2%#2 | -191.7%#8 | -6961.0%#6 | — | — | — | — | — |
| AZN | — | — | — | — | 8.6%#5 | 45.3%#5 | 23.4%#2 | 21.0%#2 | — | — | — | — |
| BCTX | $31M#7 | — | — | — | — | -449.1%#10 | — | — | — | — | -56.1%#6 | — |
| BCTXL | $8M#8 | — | — | — | — | -449.1%#10 | — | — | — | — | — | — |
| BCTXZ | $1M#9 | — | — | — | — | -449.1%#10 | — | — | — | — | -31.5%#5 | — |
| BDPT | — | — | — | — | 44.3%#3 | -73.3%#7 | -5701.8%#5 | — | — | — | — | — |
| BDRX | $300.3B#1 | — | — | — | — | — | — | — | — | — | -95.7%#8 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice